Amgen is proud to support February’s Black History Month, which focuses on a unique theme every year. This year’s − Health and Wellness – is particularly timely as the pandemic continues to negatively affect health outcomes, specifically for BIPOC (Black, Indigenous and People of Color) communities.
We’ve bundled available resources here on this page that support this year’s theme of Black Health and Wellness, including articles about the importance of clinical trial diversity (and how Amgen is addressing this), why community partnerships are key to disrupting health barriers and what needs to be done to continue to advance our diversity, inclusion and belonging journey. We invite you to read these articles as well as ones providing health information on biomarker testing, severe asthma, bone health, plaque psoriasis and heart health.
Inside Amgen’s Push for Greater Diversity in Clinical Trials
Through an internal program known as RISE (Representation in Clinical Research), Amgen is looking to create greater equity related to clinical trial diversity.
Building Partnerships to Disrupt Health Barriers
5 Lessons from Amgen’s 8th Annual Health Equity Summit.
Candid Conversations: Amgen Black Employee Network (ABEN)
In celebration of Black History Month, the first video features transparent dialogue between David Reese, executive vice president, R&D and executive sponsor of the Amgen Black Employee Network (ABEN), and Mike Edmondson, a vice president in our Global Commercial Organization and immediate past global chair of ABEN.
4 Questions About Biomarker Testing and the Critical Role It Plays in NSCLC
Biomarker testing at the time of diagnosis is a critical first step in getting patients on the right treatment plan.
Can You Answer These 6 Questions About Severe, Uncontrolled Asthma?
Learn more about this serious condition that affects millions of people around the world.
4 Ways Amgen Is Working With Organizations to Improve Osteoporosis Care and Bone Health
As the U.S. recognizes the month of May as osteoporosis awareness month, Amgen remains committed to predicting and helping prevent the impact of serious diseases like osteoporosis.
Going Beyond Skin Deep When Managing Plaque Psoriasis
We sat down with Ponda Motsepe-Ditshego, vice president, Global Medical Therapeutic Area Head, to discuss the challenges people living with plaque psoriasis may face and how Amgen research is hoping to make an impact.
Alliance for the Million Hearts Campaign Aims to Prevent One Million Heart Attacks and Strokes by 2022
Amgen has joined CDC Foundation and others in coalition to fight cardiovascular disease.
The Transformation of Amgen’s Black Employee Network: How to Impact the Business in Six Steps
Amgen’s Black Employee Network (ABEN) is a global community helping to recruit talent, develop leaders and impacting the way we ensure our medicines serve our diverse patients. Here’s how they got there.
Fellowship Program Between Amgen and Howard University Aims to Expand Talent Pool
Partnering with Historically Black Colleges and Universities will help broaden Amgen’s staff with new scientists, making the company stronger as it continues its quest to fight diseases.
Diversity, Inclusion and Belonging
Diversity matters at Amgen. We believe that an environment of inclusion fosters innovation, which drives our ability to serve patients. Our global presence is strengthened by having a workforce that reflects the diversity of the patients we serve.